Suicide incidence and PTSD prevalence significantly higher in patients with rare cancers versus common cancer types
Greater improvements reported in gratitude, anxiety, physical function at nine weeks; more improvements seen at 18 weeks
Patients with BHD are less likely to undergo resection and have increased odds of a complication
Higher risk observed with aggressive or fatal diagnosis and during the first few years after diagnosis
Prevalence of SUD highest in survivors of head and neck, esophageal and gastric, cervical cancers, and melanoma
Patients with cancer, depression report acceptability of psilocybin-assisted therapy group model
Virtual reality interventions are suggested to have positive effect on anticipatory anxiety symptoms and pain
Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering
MBIs recommended for anxiety symptoms and depression symptoms during and after cancer treatment